Turner Brings Out Three Long/Short Funds

The Turner Funds is introducing three alternative, or long/short, stock mutual funds.

The funds seek to capitalize on rising stocks in their long positions and on declining stocks in their short positions, the company reports. The three funds include:

  • Turner Market Neutral Fund, managed by Matthew Glaser, contains a balance of long and short investments in different stocks across all major market sectors. The fund has Institutional Class shares (ticker symbol: TMNEX), Investor Class shares (ticker symbol: TMNFX), and Class C shares (ticker symbol: TMNCX).  Glaser, chief of investment strategies and executive managing director, joined Turner in 2007.  He previously worked for Susquehanna International Group. 
  • Turner Medical Sciences Long/Short Fund, managed by Vijay Shankaran, is a diversified fund of long and short investments in health-care companies of all market capitalizations. The fund offers Institutional Class shares (ticker symbol: TMSEX), Investor Class shares (ticker symbol: TMSFX), and Class C shares (ticker symbol: TMSCX).  Shankaran, who is a medical doctor and holds a doctorate in immunology, is a senior portfolio manager/global security analyst.  He came to Turner in 2006 from Caxton Associates.
  • Turner Titan Fund, managed by Christopher Baggini, is a global, diversified fund of long and short investments in all major market sectors, with a focus on large cap-stocks.  The fund offers Institutional Class shares (ticker symbol: TTLEX), Investor Class shares (ticker symbol: TTLFX), and Class C shares (ticker symbol: TTLCX).  Baggini, senior portfolio manager/global security analyst has been with Turner since June of 2010. 

The minimum initial investment is $100,000 for Institutional Class shares and $2,500 for Investor Class and Class C shares.  For Individual Retirement Accounts, the minimum initial investment is $100,000 for Institutional Class shares and $2,000 for Investor Class and Class C shares.

Want the latest retirement plan adviser news and insights? Sign up for PLANADVISER newsletters.

«